Biodesix vs Personalis
BDSX and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BDSX and PSNL compare
Personalis is the larger company, worth 16 times as much as Biodesix ($1.7B against $107M).
Biodesix grew revenue faster over the last twelve months (31.2% versus 16.9% for Personalis).
Biodesix keeps more of each dollar of sales as profit, with a net margin of −25.7% compared with −148% at Personalis.
Personalis scores higher on the StockData Score (5 against 4 for Biodesix), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BDSX | PSNL |
|---|---|---|
| Size and price | ||
| Market cap | $107M | $1.7B |
| Share price | $10.12 | $15.96 |
| Change, 1 year | 34.2% | 84.9% |
| Change, 5 years | −92.1% | 6.8% |
| Beta (5Y) | 0.73 | 1.87 |
| Employees | 334 | 260 |
| StockData Score | ||
| Total score | 4 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.0× (better) | 21.1× |
| P/B | 12.3× | 8.0× (better) |
| FCF yield | −17.9% | −6.3% (better) |
| Fair value | – | $3.55 |
| Margin of safety | – | −350% |
| Growth | ||
| Revenue growth (TTM) | 31.2% (better) | 16.9% |
| Revenue growth, 5Y average | 14.2% (better) | −2.4% |
| Profitability | ||
| Gross margin | – | 16.7% |
| Operating margin | −18.7% (better) | −157% |
| Net margin | −25.7% (better) | −148% |
| FCF margin | −18.1% (better) | −133% |
| Return on equity | −779% | −62.1% (better) |
| Return on invested capital | −55.4% (better) | −465% |
| Financial health | ||
| Debt / equity | 5.43 (better) | 0.00 |
| Interest coverage | −2.5× (better) | −684.0× |
| Current ratio | 2.96 | 4.53 (better) |
| Altman Z-score | −6.23 | 9.03 (better) |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | −30.7% | −7.9% (better) |
| Shareholder yield | −30.7% | −7.9% (better) |
| Ownership | ||
| Held by institutions | 41.4% | 79.6% |
| Held by insiders | – | 15.0% |
| Insider net buying, 12 months | $3.0M (better) | −$6.9M |
| Short interest, % of float | – | 7.4% |
Go deeper
- BDSX stock overview
- BDSX income statement
- BDSX valuation and score
- PSNL stock overview
- PSNL income statement
- PSNL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.